Ormalvi Alternatives Compared
Ormalvi (dichlorphenamide) | Acetazolamide | Keveyis (dichlorphenamide) |
|
---|
Ormalvi (dichlorphenamide) | Acetazolamide | Keveyis (dichlorphenamide) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hypokalemic Periodic Paralysis, Primary Periodic Paralysis, Hyperkalemic Periodic Paralysis. Ormalvi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glaucoma, Hydrocephalus, Edema, Epilepsy, Hypokalemic Periodic Paralysis, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri, Seizure Prevention, Seizures. Acetazolamide may... View more |
Prescription only
Prescribed for Hypokalemic Periodic Paralysis, Primary Periodic Paralysis, Hyperkalemic Periodic Paralysis. Keveyis may also be used for purposes not listed in this medication guide. |
Related suggestions Hypokalemic Periodic Paralysis
|
|||||||||||||||||||||||
More about (dichlorphenamide) | More about Acetazolamide | More about Keveyis (dichlorphenamide) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Be the first to share your experience with this drug. |
Acetazolamide has an average rating of 6.4 out of 10 from a total of 192 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 26% reported a negative effect. |
Keveyis has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Ormalvi side effects |
View all Acetazolamide side effects |
View all Keveyis side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
None |
||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Ormalvi prices |
View all Acetazolamide prices |
View all Keveyis prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other dichlorphenamide brands include: Keveyis |
N/A |
Other dichlorphenamide brands include: Ormalvi | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
4 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 230 drugs are known to interact with Ormalvi:
|
A total of 263 drugs are known to interact with Acetazolamide:
|
A total of 230 drugs are known to interact with Keveyis:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
July 27, 1953 |
July 22, 1958 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.